These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25528628)

  • 1. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.
    Welinder C; Jansson B; Lindell G; Wenner J
    Cancer Lett; 2015 Mar; 358(1):43-6. PubMed ID: 25528628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer.
    Iinuma H; Okinaga K; Egami H; Mimori K; Hayashi N; Nishida K; Adachi M; Mori M; Sasako M
    Int J Oncol; 2006 Feb; 28(2):297-306. PubMed ID: 16391782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
    Cohen SJ; Alpaugh RK; Gross S; O'Hara SM; Smirnov DA; Terstappen LW; Allard WJ; Bilbee M; Cheng JD; Hoffman JP; Lewis NL; Pellegrino A; Rogatko A; Sigurdson E; Wang H; Watson JC; Weiner LM; Meropol NJ
    Clin Colorectal Cancer; 2006 Jul; 6(2):125-32. PubMed ID: 16945168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytokeratin 20 as a marker of tumor progression or dissemination in patients with colorectal cancer].
    Garrido S M; Ramírez V P; Risueño A C; Orellana U E; Galindo A H; Alvarez Z M
    Rev Med Chil; 2008 Apr; 136(4):482-90. PubMed ID: 18769791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 20 positive cells in blood of colorectal cancer patients as an unfavorable prognostic marker.
    Kust D; Šamija I; Kirac I; Radić J; Kovačević D; Kusić Z
    Acta Clin Belg; 2016 Aug; 71(4):235-43. PubMed ID: 27144776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated tumor cells and circulating CK20 mRNA in pN0 colorectal cancer patients.
    Wong CS; Cheung MT; Ma BB; Pun Hui E; Chan AC; Chan CK; Lee KC; Cheuk W; Lam MY; Wong MC; Chan CM; Chan JK; Chan AT
    Int J Surg Pathol; 2008 Apr; 16(2):119-26. PubMed ID: 18387990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay.
    Vaiopoulos AG; Kostakis ID; Gkioka E; Athanasoula KCh; Pikoulis E; Papalambros A; Christopoulos P; Gogas H; Kouraklis G; Koutsilieris M
    Anticancer Res; 2014 Jun; 34(6):3083-92. PubMed ID: 24922677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation.
    Liang H; Yang C; Zhang B; Wang H; Liu H; Zhao Z; Zhang Z; Wen X; Lai X
    Med Oncol; 2015 May; 32(5):151. PubMed ID: 25832864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
    Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients].
    Zhang XW; Fan P; Yang HY; Yang L; Chen GY
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic significance of cytokeratin 19 and 20 expression on micrometastasis of colorectal cancer].
    Yu YJ; Liu YD; Xu X; Ma XW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):48-51. PubMed ID: 19145504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
    Cohen SJ; Punt CJ; Iannotti N; Saidman BH; Sabbath KD; Gabrail NY; Picus J; Morse M; Mitchell E; Miller MC; Doyle GV; Tissing H; Terstappen LW; Meropol NJ
    J Clin Oncol; 2008 Jul; 26(19):3213-21. PubMed ID: 18591556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.